US Quality Core Implementation Guide, published by ONC. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/FHIR/us-quality-core/ and changes regularly. See the Directory of published versions
Profile: US Quality Core MedicationStatement
status: Active
medication: Medication alemtuzumab 10 MG/ML [Lemtrada]
effective: 2015-03-26 --> 2015-03-30
dateAsserted: 2015-03-25 15:00:00-0500
informationSource: Practitioner Adam Careful
dosage
text: Infuse alemtuzumab 12 mg intravenously once daily for 5 days.
timing: Once per 1 day
route: Infusion, intravenous
DoseAndRates
Dose[x] 12 mg (Details: UCUM codemg = 'mg')